1-4 of 4
Bo I. Nilsson, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Multicentre Study with Elacytarabine as Second Salvage Therapy in Patients with AML.

Susan O'Brien, M.D., David A. Rizzieri, MD, Norbert Vey, Farhad Ravandi, Utz O. Krug, Mikkael A. Sekeres, MD, MS, Mike Dennis, Adriano Venditti, MD, Tove Flem Jacobsen, Karin Staudacher, Bo I Nilsson, MD, PhD, Francis J. Giles, MB, MD, FRCPI, FRCPath
Journal: Blood
Blood (2009) 114 (22): 1042.
https://doi.org/10.1182/blood.V114.22.1042.1042
Published: 2009
Journal Articles

A Phase I/II Study with CP-4055 in Patients with Haematologic Malignancies.

Susan O’Brien, M.D., David A. Rizzieri, MD, Norbert Vey, MD, Hagop M Kantarjian, Tove Flem Jacobsen, Bo I Nilsson, MD, PhD, Karin Staudacher, Francis Giles, MD
Journal: Blood
Blood (2008) 112 (11): 949.
https://doi.org/10.1182/blood.V112.11.949.949
Published: 2008
Journal Articles

Post-Consolidation Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in AML: Long Term Follow-Up of Leukemia-Free Survival and Overall Survival.

Mats L. Brune, MD, Jacob M. Rowe, MD, Jeff Szer, MD, Donna E. Hogge, MD, John Catalano, MD, Elisabeth Wallhult, RN, Bo I. Nilsson, MD, Bengt Simonsson, MD, Ruth Spearing, MD, Stephane Allard, MD, Edward A. Stadtmauer, MD, Kristoffer Hellstrand, MD
Journal: Blood
Blood (2007) 110 (11): 1846.
https://doi.org/10.1182/blood.V110.11.1846.1846
Published: 2007
Journal Articles

Impact on Quality of Life of Postconsolidation Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in Acute Myelogenous Leukemia.

Elisabeth Wallhult, RN, John Whisnant, MD, Jacob M. Rowe, MD, Jeff Szer, MD, Dileep Bhagwat, PhD, Kristoffer Hellstrand, MD, Bo I. Nilsson, MD, Mats L. Brune, MD
Journal: Blood
Blood (2007) 110 (11): 4381.
https://doi.org/10.1182/blood.V110.11.4381.4381
Published: 2007